Beijing Anzhen Hospital: Acute Coronary Syndrome trials

The registry lists 10 Acute Coronary Syndrome studies with Beijing Anzhen Hospital as lead sponsor. 5 are open to participants now and 0 have results posted.

Phase 4 3No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• For Patients With Myocardial Infarction and Multiple Vessel: Testing if Ultrasound (UFR) Can Guide All Needed Treatment in One Procedure, Avoiding a Return Hospital Visit for a Second Operation.Not yet recruitingNCT07264881
• Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable PlaquesRecruitingNCT06855537Phase 4
• Clinical Features and Linked mEchanisms in Acute Risk-free AMINot yet recruitingNCT06716177
• Treatment of ACuTe Coronary Syndromes With Low-dose colchICineRecruitingNCT06215989Not applicable
• Registry Study on Drug Therapy and Clinical Outcomes in Patients With Acute Coronary SyndromeNot yet recruitingNCT04184583
• Bleeding Risk Assessment System for Antithrombotic Therapy of ACSStatus unknownNCT04162808
• LOwer Maintenance Dose TICagrelor in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary InterventionStatus unknownNCT04060914Phase 4
• Genotyping GUided Antiplatelet theRapy in pAtieNts Treated With Drug Eluting stEnts (GUARANTEE)Active, not recruitingNCT03783351Not applicable
• OSA-ACS Project: Association of OSA and CPAP Therapy With Outcomes in ACS PatientsCompletedNCT03362385
• Acute Rosuvastatin for Preventing Myocardial Damage in Patients With ACSStatus unknownNCT01245803Phase 4